Stocktoria
EssilorLuxottica Société anonyme EL.PA
FR · Euronext Paris · XPAR · stock · Healthcare · website
EssilorLuxottica Société anonyme financials (annual, from 10-K)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $28.5B | $26.5B | $25.4B | $24.5B |
| Gross profit | $17.3B | $16.8B | $16.0B | $15.6B |
| R&D expense | $664.0M | $630.0M | $593.0M | $600.0M |
| SG&A expense | $13.0B | $12.5B | $12.1B | $11.7B |
| Operating income | $3.4B | $3.4B | $3.2B | $3.2B |
| Interest expense | $314.0M | $253.0M | $116.0M | $156.0M |
| Income tax | $752.0M | $800.0M | $609.0M | $751.0M |
| Net income | $2.3B | $2.4B | $2.3B | $2.2B |
| EPS (diluted) | $4.98 | $5.13 | $5.08 | $4.83 |
| Operating cash flow | $5.3B | $4.9B | $4.9B | $4.8B |
| Free cash flow | $3.8B | $3.4B | $3.3B | $3.2B |
| Cash & equivalents | $3.5B | $2.3B | $2.6B | $2.0B |
| Inventory | $3.5B | $3.2B | $2.8B | $2.8B |
| Total assets | $63.9B | $64.3B | $60.5B | $60.6B |
| Total liabilities | $24.4B | $23.3B | $21.6B | $22.4B |
| Shareholders' equity | $38.9B | $40.4B | $38.2B | $37.5B |
Growth · year-over-year · Revenue CAGR 5.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +7.5% | +4.4% | +3.7% | — |
| Net income growth | -1.9% | +3.1% | +6.4% | — |
| EPS growth | -2.9% | +1.0% | +5.2% | — |
| Free cash flow growth | +12.4% | +0.7% | +3.7% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: company filings via Yahoo Finance · FR · as of 2025-12-31. Figures in EUR; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.